ReDura
Commercial- Indications
- Neurosurgery
Company intelligence / Profile preview
Clinical results show that the company's Dural Repair Patch facilitates cell migration/growth and effective meningeal regeneration with gradual absorption of the material. A multi-center randomized controlled trial was conducted to evaluate safety/effectiveness of their dura patch. Another Phase 3 trial evaluated their Regen Sling for female stress urinary incontinence. Products have been widely adopted globally (>500,000 patients), with strong safety/efficacy profiles reported by users and KOLs.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medprin Regenerative Medical Technologies.